EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New Dihalogenated Derivatives of Condensed Benzimidazole Diones Promotes Cancer Cell Death Through Regulating STAT3/HK2 Axis/Pathway

Yulia Aleksandrova iD, Luiza Savina, Inna Shagina iD, Anna Lyubina iD, Alla Zubishina, Svetlana Makarova iD, Anna Bagylly, Alexander Khokhlov, Roman Begunov, Margarita Neganova iD

Molecules · 22.10.2025 · 30 (21) · 4150

DOI: 10.3390/molecules30214150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 22.10.2025. Verfasst von Yulia Aleksandrova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Yaroslavl State Medical University of the Ministry of Health of the Russian Federation, Yaroslavl 150000, Russia. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Benzimidazoles, Antineoplastic Agents, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal State Budgetary Educational Institution of Higher Education "Yaroslavl State Medical University" of the Ministry of Health of the Russian Federation, Federal State Budgetary Educational Institution of Higher Education “Yaroslavl State Medical University” of the Ministry of Health of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An effective method for synthesizing dihalogenated derivatives of condensed benzimidazole diones with a nodal nitrogen atom has been developed. As a result, five new heterocyclic quinones were obtained, which differed in the structure of the heterocycle annelated to imidazole, as well as the nature and arrangement of halogen atoms. A comprehensive analysis of the anticancer potential of new heterocyclic quinones revealed pronounced cytotoxic activity of the molecules against tumor cells. Using in silico methods for predicting activity spectra, it was found that the synthesized compounds are capable of interacting with a number of key targets that play an important role in oncogenesis, with the highest probability of binding to STAT3, the central regulator of cell growth, proliferation and metabolism. Experimental studies have shown that, despite the lack of pronounced ability to induce apoptosis, these substances effectively inhibit the activity of allosteric glycolytic enzymes, disrupting metabolic adaptation and energy balance of tumor cells. The obtained results expand the understanding of the molecular basis of the antitumor action of heterocyclic compounds and lay a solid foundation for their use as promising modulators of tumor cell metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorBenzimidazolesAntineoplastic AgentsSignal TransductionNeoplasmsHumansCell Line, TumorApoptosisCell ProliferationHalogenationMolecular Docking SimulationMolecular StructureCell Death

Stichwörter der Autor:innen

STAT3antitumor agentsapoptosiscondensed benzimidazole dionescytotoxic profileglycolysisin silico screeningoxidation of aromatic aminesreduction of nitrohetarenesreductive intramolecular heterocyclization of ortho-nitro-tert-anilinesregioselectivity of the SEAr reaction

Substanzen

STAT3 Transcription FactorBenzimidazolesAntineoplastic AgentsSTAT3 protein, human

Autor:innen und Institutionen

  • Institute of Pharmacy, Yaroslavl State Medical University of the Ministry of Health of the Russian Federation, Yaroslavl 150000, Russia.
  • Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Moscow 119991, Russia.
  • Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Kazan 420088, Russia.

ORCID-Profile: Yulia Aleksandrova, Inna Shagina, Anna Lyubina, Svetlana Makarova, Margarita Neganova

Förderung

  • Federal State Budgetary Educational Institution of Higher Education "Yaroslavl State Medical University" of the Ministry of Health of the Russian Federation
  • Federal State Budgetary Educational Institution of Higher Education “Yaroslavl State Medical University” of the Ministry of Health of the Russian Federation

Zitieren

APA

Aleksandrova, Y., Savina, L., Shagina, I., Lyubina, A., Zubishina, A., Makarova, S., Bagylly, A., Khokhlov, A., Begunov, R., & Neganova, M. (2025). New Dihalogenated Derivatives of Condensed Benzimidazole Diones Promotes Cancer Cell Death Through Regulating STAT3/HK2 Axis/Pathway. Molecules, 30(21), 4150. https://doi.org/10.3390/molecules30214150

Vancouver

Aleksandrova Y, Savina L, Shagina I, Lyubina A, Zubishina A, Makarova S, et al. New Dihalogenated Derivatives of Condensed Benzimidazole Diones Promotes Cancer Cell Death Through Regulating STAT3/HK2 Axis/Pathway. Molecules. 2025;30(21):4150. doi:10.3390/molecules30214150

BibTeX
@article{Aleksandrova2025,
  author = {Aleksandrova, Yulia and Savina, Luiza and Shagina, Inna and Lyubina, Anna and Zubishina, Alla and Makarova, Svetlana and Bagylly, Anna and Khokhlov, Alexander and Begunov, Roman and Neganova, Margarita},
  title = {New Dihalogenated Derivatives of Condensed Benzimidazole Diones Promotes Cancer Cell Death Through Regulating STAT3/HK2 Axis/Pathway},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {21},
  pages = {4150},
  doi = {10.3390/molecules30214150}
}
Kostenlos starten →